» Articles » PMID: 33716723

Mesenchymal Stem Cell-Derived Exosomes: A Promising Biological Tool in Nanomedicine

Overview
Journal Front Pharmacol
Date 2021 Mar 15
PMID 33716723
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

As nano-scale biological vesicles, extracellular vesicles (EVs)/exosomes, in particular, exosomes derived from mesenchymal stem cells (MSC-exosomes), have been studied in the diagnosis, prevention, and treatment of many diseases. In addition, through the combination of nanotechnology and biotechnology, exosomes have emerged as innovative tools for the development of nanomedicine. This review focuses on a profound summarization of MSC-exosomes as a powerful tool in bionanomedicine. It systemically summarizes the role of MSC-exosomes as a nanocarrier, drug loading and tissue engineering, and their potential contribution in a series of diseases as well as the advantages of exosomes over stem cells and synthetic nanoparticles and potential disadvantages. The in-depth understanding of the functions and mechanisms of exosomes provides insights into the basic research and clinical transformation in the field of nanomedicine.

Citing Articles

Recent advancements in nanoparticles for cancer treatment.

Sharma D Med Oncol. 2025; 42(3):72.

PMID: 39928091 DOI: 10.1007/s12032-025-02609-4.


Cutting-edge insights into liver fibrosis: advanced therapeutic strategies and future perspectives using engineered mesenchymal stem cell-derived exosomes.

Didamoony M, Soubh A, Ahmed L Drug Deliv Transl Res. 2025; .

PMID: 39853531 DOI: 10.1007/s13346-024-01784-7.


Mesenchymal stromal cell exosomes for drug delivery of prostate cancer treatments: a review.

Wang C, Feng Y, Rong X, Yan J, Lv B, Jiang H Stem Cell Res Ther. 2025; 16(1):18.

PMID: 39849570 PMC: 11755940. DOI: 10.1186/s13287-025-04133-8.


Exosomes derived from microRNA-540-3p overexpressing mesenchymal stem cells promote immune tolerance the CD74/nuclear factor-kappaB pathway in cardiac allograft.

He J, Wu X, Li S, Yan D, Xiao G, Mao F World J Stem Cells. 2024; 16(12):1022-1046.

PMID: 39734479 PMC: 11669987. DOI: 10.4252/wjsc.v16.i12.1022.


The Opportunities and Challenges of Mesenchymal Stem Cells-Derived Exosomes in Theranostics and Regenerative Medicine.

Yadav S, Maity P, Kapat K Cells. 2024; 13(23).

PMID: 39682706 PMC: 11640604. DOI: 10.3390/cells13231956.


References
1.
Witwer K, van Balkom B, Bruno S, Choo A, Dominici M, Gimona M . Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicles. 2019; 8(1):1609206. PMC: 6493293. DOI: 10.1080/20013078.2019.1609206. View

2.
Gurunathan S, Kang M, Jeyaraj M, Qasim M, Kim J . Review of the Isolation, Characterization, Biological Function, and Multifarious Therapeutic Approaches of Exosomes. Cells. 2019; 8(4). PMC: 6523673. DOI: 10.3390/cells8040307. View

3.
Webb R, Kaiser E, Jurgielewicz B, Spellicy S, Scoville S, Thompson T . Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke. Stroke. 2018; 49(5):1248-1256. PMC: 5916046. DOI: 10.1161/STROKEAHA.117.020353. View

4.
Blazquez R, Sanchez-Margallo F, de la Rosa O, Dalemans W, Alvarez V, Tarazona R . Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on in vitro Stimulated T Cells. Front Immunol. 2014; 5:556. PMC: 4220146. DOI: 10.3389/fimmu.2014.00556. View

5.
Mendt M, Kamerkar S, Sugimoto H, McAndrews K, Wu C, Gagea M . Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018; 3(8). PMC: 5931131. DOI: 10.1172/jci.insight.99263. View